Cytokines, breast cancer stem cells (BCSCs) and chemoresistance

Author:

Chen Weilong1,Qin Yuanyuan1,Liu Suling2

Affiliation:

1. School of Life ScienceThe CAS Key Laboratory of Innate Immunity and Chronic DiseaseUniversity of Science & Technology of China230027HefeiAnhuiChina

2. Fudan University Shanghai Cancer Center & Institutes of Biomedical Sciences; Cancer Institutes; Key Laboratory of Breast Cancer in Shanghai; Key Laboratory of Medical Epigenetics and Metabolism; Innovation Center for Cell Signaling NetworkShanghai Medical College; Fudan University200032ShanghaiChina

Funder

National Natural Science Foundation of China

National Basic Research Program of China

NSFC grant

the National Key Research and Development Program of China

MOST grant

NSFC grants

Publisher

Wiley

Subject

Molecular Medicine,Medicine (miscellaneous)

Reference124 articles.

1. Cancer statistics, 2018

2. Incorporating gold nanoclusters and target‐directed liposomes as a synergistic amplified colorimetric sensor for HER2‐positive breast cancer cell detection;Tao Y;Theranostics.,2017

3. HwangKT KimEK JungSH LeeES KimSI LeeSet al (2018)Tamoxifen therapy improves overall survival in luminal A subtype of ductal carcinoma in situ: a study based on nationwide Korean Breast Cancer Registry database. Breast Cancer Res Treat.https://doi.org/10.1007/s10549‐018‐4681‐6

4. Cancer: tumour stem‐cell surprises;Greten FR;Nature,2017

5. Protracted dormancy of pre-leukemic stem cells

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3